data_1cz4_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1cz4 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.6 mtp . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.28 0.562 . . . . 10.73 110.172 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.409 ' HG2' ' HB2' ' A' ' 4' ' ' ASN . 85.8 tt0 -59.94 -40.07 87.71 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.307 -0.871 . . . . 6.68 110.061 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.0 m 51.82 49.97 19.64 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.249 -0.907 . . . . 5.79 110.322 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.409 ' HB2' ' HG2' ' A' ' 2' ' ' GLU . 11.4 t-20 -93.55 120.24 33.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.264 -0.898 . . . . 4.08 110.278 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -148.14 -170.76 3.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.293 -0.88 . . . . 3.2 109.97 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 88' ' ' ARG . . . -147.4 -159.72 8.5 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.523 -1.431 . . . . 0.86 109.523 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.486 ' CD1' HD22 ' A' ' 33' ' ' LEU . 43.6 pt -139.6 152.04 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.242 -1.152 . . . . 1.33 110.007 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 96.7 mt -97.42 119.61 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.316 -0.865 . . . . 1.69 109.81 178.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.51 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 2.2 pt? -135.87 -168.34 2.2 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.307 -0.871 . . . . 1.92 110.255 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.552 ' CG ' ' HA2' ' A' ' 82' ' ' GLY . 26.5 ttm105 -106.0 130.69 53.88 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.302 -0.874 . . . . 3.91 111.023 -174.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.523 ' CG1' ' N ' ' A' ' 82' ' ' GLY . 14.4 p -61.66 139.02 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.473 -0.767 . . . . 1.44 110.379 177.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.6 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -120.26 153.57 36.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.342 -0.849 . . . . 1.27 110.481 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.418 ' HB3' ' CD1' ' A' ' 81' ' ' ILE . 86.5 tt0 -176.43 148.45 0.75 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.247 -0.908 . . . . 1.84 110.297 175.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -130.39 159.97 35.42 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.314 -0.866 . . . . 2.53 110.358 -177.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -52.01 -27.04 12.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.331 -0.856 . . . . 6.0 110.384 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.447 ' O ' ' OD1' ' A' ' 18' ' ' ASP . 60.1 p -59.94 159.86 8.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.13 -0.981 . . . . 6.36 110.076 -177.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.469 ' O ' ' C ' ' A' ' 18' ' ' ASP . 81.9 p -60.0 -40.03 87.82 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.199 -0.938 . . . . 5.65 110.395 -176.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.553 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 4.7 p-10 36.43 59.97 3.35 Favored Pre-proline 0 N--CA 1.499 2.022 0 O-C-N 121.471 -0.768 . . . . 4.34 110.573 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.553 ' HD3' ' N ' ' A' ' 18' ' ' ASP . 17.3 Cg_exo -62.0 167.37 10.69 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.919 1.484 . . . . 4.27 110.526 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.71 83.35 1.67 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.779 -1.328 . . . . 1.97 109.779 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.455 ' HE2' HG11 ' A' ' 72' ' ' VAL . 23.7 ptm -89.81 -10.02 46.99 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.242 -1.152 . . . . 2.71 110.092 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 94.1 p -99.39 1.9 44.71 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.242 -0.911 . . . . 2.31 110.081 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.604 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 84.2 mtt85 -110.89 129.46 55.87 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.417 -0.802 . . . . 3.8 109.906 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.503 ' O ' ' N ' ' A' ' 55' ' ' TYR . 77.9 t -109.95 115.4 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.012 -1.055 . . . . 1.31 109.973 177.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.519 ' O ' ' CG ' ' A' ' 25' ' ' ARG . 0.7 OUTLIER -88.09 117.43 26.96 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 118.81 -1.156 . . . . 3.09 109.695 178.389 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 mp -129.12 172.61 11.24 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.757 -0.589 . . . . 2.89 109.562 -177.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.538 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 7.0 p-10 -92.75 176.65 6.36 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.927 -1.108 . . . . 1.47 110.057 178.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -59.99 -40.01 87.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.191 -0.943 . . . . 2.11 109.482 -176.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.571 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 47.6 t -69.57 -44.91 69.88 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.434 -0.791 . . . . 1.89 110.564 -177.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.615 ' HA ' ' CD2' ' A' ' 33' ' ' LEU . 58.8 m -60.03 -39.98 87.75 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.091 -1.006 . . . . 1.88 109.578 177.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.448 ' HG3' ' HB1' ' A' ' 36' ' ' ALA . 36.9 ttp180 -74.75 -43.39 55.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.765 -0.584 . . . . 3.25 111.428 177.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.6 ttp180 -91.37 -11.55 37.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.836 -1.165 . . . . 3.91 111.216 -169.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.615 ' CD2' ' HA ' ' A' ' 30' ' ' SER . 1.3 pp -58.68 -32.84 69.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.864 -1.147 . . . . 2.09 109.594 -178.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.603 ' N ' ' CD1' ' A' ' 33' ' ' LEU . 13.0 mt -105.23 -74.05 0.66 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.192 -0.943 . . . . 2.45 110.309 175.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.559 ' O ' ' C ' ' A' ' 36' ' ' ALA . 45.6 t0 -170.17 -24.56 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.642 -0.661 . . . . 2.02 109.921 -179.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.559 ' C ' ' O ' ' A' ' 35' ' ' ASP . . . -24.57 119.19 0.05 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.58 0.705 . . . . 1.38 111.383 -177.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.517 ' O ' HG12 ' A' ' 54' ' ' VAL . 1.1 pt-20 -105.72 175.14 5.6 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.886 -0.783 . . . . 2.64 108.886 175.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 26.1 mm -58.17 120.78 4.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 120.96 -1.087 . . . . 3.34 109.835 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.66 33.85 54.88 Favored Glycine 0 N--CA 1.487 2.092 0 C-N-CA 119.961 -1.114 . . . . 1.2 110.395 174.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.513 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 35.1 m-20 -89.15 177.11 6.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.742 -1.446 . . . . 1.33 109.463 171.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.533 HG21 ' CG2' ' A' ' 92' ' ' THR . 70.4 t -99.04 121.6 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.985 -1.072 . . . . 1.12 110.241 -176.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.442 HG23 ' C ' ' A' ' 52' ' ' GLY . 1.5 m -116.8 139.43 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.34 -0.85 . . . . 1.16 110.471 -176.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -106.83 141.31 38.26 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.397 -0.815 . . . . 1.44 109.866 177.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.714 ' HB ' ' OG1' ' A' ' 50' ' ' THR . 2.1 mp -120.46 146.6 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 120.965 -1.084 . . . . 1.5 110.33 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 85.9 tt0 -150.9 97.12 2.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.251 -0.906 . . . . 1.39 110.971 -178.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.54 ' CG ' HG13 ' A' ' 85' ' ' VAL . 1.7 tmtt? -98.39 -67.35 0.85 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.063 -1.023 . . . . 2.44 109.829 173.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.532 HG23 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -101.02 -35.42 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 121.775 0.797 . . . . 1.6 109.158 174.299 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.492 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 72.0 mtt85 -135.46 -178.74 5.25 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.775 -0.578 . . . . 3.66 109.592 178.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.501 ' O ' HD21 ' A' ' 130' ' ' LEU . 28.0 mttt -89.06 137.14 32.59 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.251 -0.906 . . . . 3.05 110.62 -177.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.714 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 10.9 p -140.55 166.81 23.71 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.4 0.619 . . . . 1.6 109.835 177.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.545 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.1 OUTLIER -123.01 166.18 18.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 121.466 -0.771 . . . . 1.24 110.217 -179.715 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.442 ' C ' HG23 ' A' ' 42' ' ' VAL . . . -178.97 -169.5 39.65 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 108.843 -1.703 . . . . 0.5 108.843 176.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -129.96 162.79 27.85 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.335 -1.097 . . . . 3.42 110.169 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.517 HG12 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -89.01 138.83 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.193 -0.942 . . . . 1.28 110.427 -173.843 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.604 ' CZ ' ' HD3' ' A' ' 23' ' ' ARG . 2.2 m-85 -134.74 166.32 23.22 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.528 -0.733 . . . . 1.63 110.251 177.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.501 ' HG3' ' O ' ' A' ' 56' ' ' ARG . 51.9 ptt85 -90.68 128.4 36.63 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.254 -0.904 . . . . 4.54 110.213 178.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.445 ' HB3' ' CG ' ' A' ' 63' ' ' ASN . . . -65.93 140.01 58.3 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.277 -0.89 . . . . 1.45 109.813 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.578 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -54.77 -49.54 90.98 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 120.914 -1.116 . . . . 4.63 108.845 175.485 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.578 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 35.4 Cg_endo -92.73 98.83 0.17 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.87 1.458 . . . . 3.13 108.877 178.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -73.53 34.38 0.08 Allowed 'General case' 0 C--N 1.29 -1.986 0 O-C-N 121.422 -0.799 . . . . 2.74 110.912 -174.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.431 ' H ' ' C ' ' A' ' 59' ' ' PRO . 54.6 t0 -146.25 -27.57 0.42 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.134 -0.979 . . . . 3.29 110.78 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -86.09 -28.18 24.21 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.122 -0.986 . . . . 3.64 109.258 178.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.494 ' HA ' ' CG1' ' A' ' 66' ' ' ILE . 33.4 m-80 -81.79 43.6 0.77 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.725 -0.61 . . . . 4.02 110.301 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.456 ' HA ' ' CG ' ' A' ' 27' ' ' ASP . 30.3 pttt -97.43 8.95 43.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.302 -0.874 . . . . 4.77 109.38 177.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -179.89 27.13 0.05 OUTLIER Glycine 0 N--CA 1.48 1.567 0 N-CA-C 109.383 -1.487 . . . . 1.23 109.383 177.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.494 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 43.4 pt -140.28 142.9 30.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.364 -1.08 . . . . 1.54 109.376 175.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.482 HG13 ' O ' ' A' ' 67' ' ' VAL . 3.1 p -119.99 121.1 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.032 -1.043 . . . . 1.22 110.082 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.6 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 97.3 mtt180 -89.82 116.05 27.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.077 -1.014 . . . . 4.4 110.239 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.5 pt -126.76 171.7 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 CA-C-O 121.471 0.653 . . . . 1.43 110.633 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -80.01 168.09 19.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.533 -0.729 . . . . 1.98 109.837 177.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 75.0 m -59.98 -40.0 87.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.233 -0.917 . . . . 2.26 110.359 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.51 ' O ' ' ND2' ' A' ' 76' ' ' ASN . 54.5 t -62.83 -43.65 98.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.2 -0.937 . . . . 2.03 110.203 -177.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.47 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 0.0 OUTLIER -59.99 -46.51 89.24 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.179 -0.951 . . . . 1.62 109.625 177.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.403 ' HD3' ' OE1' ' A' ' 13' ' ' GLU . 6.4 ttp-105 -60.17 -39.97 88.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.145 -0.972 . . . . 5.32 109.579 174.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -69.97 -23.89 63.24 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.316 -0.865 . . . . 1.97 110.478 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 72' ' ' VAL . 4.2 m120 -60.01 -39.12 84.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.124 -0.985 . . . . 2.07 110.386 -177.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.492 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 31.5 p -98.24 -35.05 10.48 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.035 -1.041 . . . . 2.3 110.545 -175.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.532 ' C ' HG23 ' A' ' 47' ' ' VAL . . . 112.46 26.62 4.18 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.67 -1.372 . . . . 1.12 109.67 176.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.445 ' CB ' ' HD2' ' A' ' 46' ' ' LYS . . . -103.46 169.99 8.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.219 -1.165 . . . . 1.56 110.303 -175.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.476 ' O ' HG12 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -112.45 178.76 4.19 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.21 -0.931 . . . . 1.33 109.368 178.267 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.487 ' HA ' HG13 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -64.8 141.27 18.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 121.004 -1.06 . . . . 1.37 110.342 177.492 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.552 ' HA2' ' CG ' ' A' ' 10' ' ' ARG . . . 78.65 -3.84 62.48 Favored Glycine 0 N--CA 1.48 1.603 0 N-CA-C 110.021 -1.231 . . . . 0.68 110.021 172.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.516 ' HB2' HG12 ' A' ' 11' ' ' VAL . 1.2 m-20 -57.29 -167.57 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.174 0 O-C-N 120.911 -1.346 . . . . 1.5 110.062 175.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.543 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 50.8 pttt -127.03 114.68 18.1 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.139 -0.976 . . . . 2.29 109.736 178.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.54 HG13 ' CG ' ' A' ' 46' ' ' LYS . 1.1 m -119.36 155.58 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.169 -0.957 . . . . 1.21 110.095 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 83.6 tttt -105.64 125.48 51.04 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.333 -0.854 . . . . 2.38 110.036 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.457 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 74.6 t -106.82 121.35 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.248 -0.908 . . . . 1.13 110.092 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.5 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 41.4 mtm180 -110.58 135.59 50.98 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.313 -0.867 . . . . 3.04 109.568 178.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.486 ' HD2' ' N ' ' A' ' 36' ' ' ALA . 19.4 tttt -83.84 138.62 33.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.084 -1.01 . . . . 1.73 110.3 -178.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.466 ' O ' ' HB ' ' A' ' 41' ' ' VAL . 2.3 m -150.02 -168.69 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.472 -0.768 . . . . 1.2 110.134 178.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -126.49 169.0 13.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.448 -0.783 . . . . 3.49 109.927 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.533 ' CG2' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -98.72 163.45 12.63 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.06 -1.025 . . . . 1.35 111.026 -175.116 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.418 ' OE2' HG23 ' A' ' 160' ' ' VAL . 12.5 pt-20 -150.1 169.45 21.22 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.093 -0.706 . . . . 1.45 109.093 175.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.9 mm -89.61 100.43 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.608 -1.307 . . . . 1.53 110.503 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.527 ' CB ' HG22 ' A' ' 162' ' ' VAL . . . -56.84 138.22 53.82 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.295 -0.878 . . . . 1.16 110.261 177.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.564 ' O ' ' N ' ' A' ' 169' ' ' LYS . 16.9 ptpt -96.7 -29.36 13.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.21 -0.931 . . . . 2.85 110.988 -179.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 169' ' ' LYS . 16.1 tttp -150.68 124.65 9.27 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.744 -1.222 . . . . 2.57 110.872 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.447 HG12 HG12 ' A' ' 170' ' ' ILE . 5.4 p -134.35 142.03 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.13 -0.981 . . . . 1.15 110.622 178.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.525 ' HB ' ' HB3' ' A' ' 154' ' ' LYS . 86.7 m -118.5 141.74 48.27 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.353 -0.842 . . . . 1.3 110.098 -178.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 152' ' ' VAL . 0.1 OUTLIER -139.26 169.78 17.14 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.248 -0.907 . . . . 2.02 110.701 -178.11 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.556 ' CB ' ' HD2' ' A' ' 173' ' ' ARG . . . -141.16 99.69 6.51 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.367 -0.833 . . . . 1.34 110.602 -176.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.491 ' HB3' ' CD1' ' A' ' 110' ' ' LEU . 22.5 Cg_exo -60.27 125.99 18.93 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.916 1.482 . . . . 1.09 110.221 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.548 HD11 ' CD1' ' A' ' 149' ' ' LEU . 83.4 mt -91.99 106.37 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.193 -0.942 . . . . 2.56 110.805 -177.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.6 ' CD1' ' HB2' ' A' ' 108' ' ' GLN . 1.9 pt -150.54 -173.91 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.224 -0.923 . . . . 1.76 110.33 173.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.42 ' O ' ' HG2' ' A' ' 108' ' ' GLN . 82.4 mtp180 -140.62 -135.54 0.11 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.507 -0.745 . . . . 4.32 109.869 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 16.9 mmtt -59.88 -13.48 11.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.925 -1.109 . . . . 3.25 109.491 175.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.506 ' OD2' ' HB2' ' A' ' 145' ' ' GLN . 54.2 p-10 -99.88 28.73 4.58 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.299 0.571 . . . . 2.09 109.819 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.6 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 12.8 pt20 -82.83 109.77 17.26 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.286 -0.883 . . . . 3.37 109.988 -177.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 38.1 ttt85 -111.76 -13.42 13.72 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.641 -0.662 . . . . 4.96 110.083 -178.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.491 ' CD1' ' HB3' ' A' ' 102' ' ' PRO . 0.8 OUTLIER -99.25 52.26 0.95 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.318 -0.863 . . . . 2.25 110.029 -178.53 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.428 ' O ' ' CD1' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -140.03 135.02 32.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.453 -0.779 . . . . 3.37 109.865 176.75 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.428 ' CD1' ' O ' ' A' ' 111' ' ' LYS . 10.0 m-85 -142.77 -40.06 0.33 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.184 -0.948 . . . . 3.16 110.458 -177.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 114' ' ' GLU . . . 75.88 -176.24 51.29 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 108.978 -1.649 . . . . 2.13 108.978 -176.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.46 ' O ' ' O ' ' A' ' 113' ' ' GLY . 75.1 mm-40 41.48 94.45 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.186 -1.185 . . . . 2.47 110.002 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.17 -7.42 75.47 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.594 -1.403 . . . . 1.16 109.594 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.405 ' CG2' ' N ' ' A' ' 117' ' ' GLU . 10.4 tp -60.02 -35.92 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.225 -1.162 . . . . 2.05 110.151 177.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.405 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 43.5 mt-10 -59.97 -40.51 89.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.161 -0.962 . . . . 1.51 109.695 178.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -68.72 -38.94 80.61 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.174 -0.954 . . . . 2.15 109.961 172.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -60.02 -40.05 87.95 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.269 -0.894 . . . . 1.95 109.359 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.545 ' CG1' HD12 ' A' ' 170' ' ' ILE . 55.1 t -66.99 -45.89 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.187 -0.945 . . . . 1.35 109.931 174.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.558 ' O ' ' HB ' ' A' ' 125' ' ' ILE . 4.2 mt-30 -60.01 -44.41 94.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.423 -0.798 . . . . 1.87 109.967 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 51.9 ttt180 -60.05 -48.63 80.91 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 121.456 0.646 . . . . 3.63 110.126 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.05 -40.09 75.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.433 -0.792 . . . . 1.49 110.512 -178.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.609 ' N ' ' CD2' ' A' ' 124' ' ' LEU . 3.9 mm? -97.57 -0.04 46.55 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.253 -0.904 . . . . 2.49 110.862 -175.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.558 ' HB ' ' O ' ' A' ' 121' ' ' GLN . 2.5 tt -47.31 166.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 120.754 -1.216 . . . . 1.71 110.184 -175.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.528 ' N ' ' O ' ' A' ' 164' ' ' ILE . 34.1 ptt180 33.07 46.68 0.1 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.63 -0.669 . . . . 2.85 111.613 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.511 ' HB2' ' O ' ' A' ' 124' ' ' LEU . 7.6 mmt180 -129.82 150.39 75.71 Favored Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 120.687 -1.258 . . . . 3.23 111.189 176.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.726 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 22.1 Cg_endo -67.21 130.78 23.41 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 124.179 1.621 . . . . 0.98 109.871 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.518 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 87.7 mmm -127.17 137.63 52.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.553 -1.342 . . . . 2.44 111.074 -177.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.519 ' CD2' ' CA ' ' A' ' 50' ' ' THR . 10.9 tp -140.23 113.64 8.55 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.668 -0.645 . . . . 1.79 109.517 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.541 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 1.0 OUTLIER -45.2 146.66 0.87 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.857 -1.152 . . . . 1.7 110.388 -176.924 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.541 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 73.84 -0.48 3.35 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.728 -0.607 . . . . 1.96 110.603 179.576 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.518 ' HB3' ' O ' ' A' ' 130' ' ' LEU . 3.2 p30 -69.97 -176.22 1.07 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.032 -1.043 . . . . 1.14 110.008 174.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -145.93 150.03 35.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.297 -0.877 . . . . 1.14 109.595 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.451 ' O ' ' HB2' ' A' ' 149' ' ' LEU . 0.2 OUTLIER -134.28 170.4 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.046 -1.034 . . . . 2.24 110.175 -179.575 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.6 t -136.51 165.8 25.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.4 -0.812 . . . . 3.2 110.539 -176.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.585 ' CG1' ' HD2' ' A' ' 138' ' ' PRO . 2.7 t -112.06 147.82 37.74 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.392 -0.818 . . . . 3.21 109.723 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.585 ' HD2' ' CG1' ' A' ' 137' ' ' VAL . 1.4 Cg_endo -46.53 177.87 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.873 1.459 . . . . 4.49 110.592 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.21 68.61 0.03 OUTLIER Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.983 -1.247 . . . . 4.35 109.983 -176.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.652 ' O ' HD12 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -130.0 154.81 47.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.207 -1.172 . . . . 6.34 111.015 179.237 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.564 ' OG1' ' N ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER 176.97 -167.5 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.996 -1.065 . . . . 5.16 110.263 -178.141 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.564 ' N ' ' OG1' ' A' ' 141' ' ' THR . 0.5 OUTLIER -146.06 -122.84 0.07 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.544 -0.723 . . . . 6.2 109.853 178.151 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.515 ' O ' ' O ' ' A' ' 142' ' ' LEU . . . -52.81 -161.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.141 -0.974 . . . . 7.24 110.002 177.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -79.02 80.0 1.54 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.288 -1.525 . . . . 6.87 109.288 173.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.506 ' HB2' ' OD2' ' A' ' 107' ' ' ASP . 1.9 pt20 -94.92 165.19 12.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.358 -1.084 . . . . 5.56 110.07 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.8 t -140.04 153.72 46.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.208 -0.932 . . . . 6.12 110.429 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.542 ' O ' ' HG ' ' A' ' 148' ' ' LEU . . . 80.21 -90.52 1.31 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.058 -1.617 . . . . 4.9 109.058 -178.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.558 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 0.4 OUTLIER 42.53 48.53 4.62 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.511 -0.994 . . . . 3.59 110.802 176.502 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.548 ' CD1' HD11 ' A' ' 103' ' ' ILE . 2.6 pp -137.17 164.49 28.34 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.97 -1.081 . . . . 2.21 109.567 176.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -91.63 137.68 32.17 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.086 -1.009 . . . . 2.56 110.234 -178.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -122.37 101.91 7.78 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.305 -0.872 . . . . 2.84 109.577 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.499 ' CG2' ' OD2' ' A' ' 133' ' ' ASP . 2.3 t -77.47 138.83 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.222 -0.924 . . . . 1.14 110.087 -177.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 4.2 t -129.71 -21.94 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.142 -0.974 . . . . 1.57 111.096 -177.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.525 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 10.5 tptm -139.91 129.84 24.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.69 -1.257 . . . . 3.26 110.935 -179.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.455 HG22 ' CA ' ' A' ' 131' ' ' GLU . 67.2 p -130.49 164.58 24.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.465 -0.772 . . . . 1.33 109.26 173.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.661 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -89.3 -36.67 0.42 Allowed Pre-proline 0 C--N 1.3 -1.576 0 O-C-N 121.159 -0.963 . . . . 2.21 110.886 -176.568 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.661 ' CD ' ' N ' ' A' ' 156' ' ' LEU . 31.4 Cg_exo -53.07 -174.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.419 0 O-C-N 123.407 1.214 . . . . 0.95 110.397 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.485 ' O ' ' HB2' ' A' ' 159' ' ' LYS . 5.0 t -86.83 41.5 0.96 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.264 -0.897 . . . . 1.61 110.239 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 158' ' ' SER . 40.7 mmtm 61.33 19.58 10.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.525 -0.734 . . . . 4.67 109.878 -176.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.468 HG13 ' O ' ' A' ' 158' ' ' SER . 23.3 m -102.25 159.91 27.94 Favored Pre-proline 0 C--N 1.304 -1.399 0 O-C-N 121.377 -0.827 . . . . 1.4 109.779 175.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.545 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 5.4 Cg_endo -53.8 119.63 6.57 Favored 'Trans proline' 0 C--N 1.3 -2.024 0 O-C-N 124.078 1.567 . . . . 0.81 110.212 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.726 ' O ' ' HA ' ' A' ' 128' ' ' PRO . 5.1 m -126.57 158.33 36.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.266 -0.896 . . . . 1.42 109.874 176.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 127' ' ' ARG . 86.5 tt0 -104.58 128.7 52.65 Favored 'General case' 0 C--N 1.292 -1.901 0 O-C-N 121.188 -0.945 . . . . 1.75 110.063 177.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' A' ' 126' ' ' ARG . 12.9 mm -71.05 152.69 8.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.678 -0.639 . . . . 1.34 109.81 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -140.11 168.26 25.15 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.042 -1.623 . . . . 1.16 109.042 175.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -56.3 -20.88 20.83 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.344 -1.092 . . . . 2.37 110.015 -177.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -91.02 -18.52 24.48 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.329 -0.857 . . . . 2.14 110.683 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.556 ' O ' ' NE2' ' A' ' 121' ' ' GLN . 30.6 m -57.95 148.43 25.83 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.182 -0.949 . . . . 1.27 110.486 -178.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.564 ' N ' ' O ' ' A' ' 96' ' ' LYS . 49.6 mttp -96.33 147.16 24.08 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.054 -1.029 . . . . 3.6 109.733 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.545 HD12 ' CG1' ' A' ' 120' ' ' VAL . 1.8 mt -130.04 160.01 41.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.093 -1.004 . . . . 1.52 110.984 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.476 ' OE1' ' OG1' ' A' ' 99' ' ' THR . 25.3 mt-10 -137.78 133.6 34.25 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.767 -0.583 . . . . 1.37 110.215 176.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.438 ' CD1' HD12 ' A' ' 100' ' ' LEU . 39.4 mm -120.02 119.98 61.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.359 -0.838 . . . . 1.83 109.415 177.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.556 ' HD2' ' CB ' ' A' ' 101' ' ' ALA . 4.7 ptp85 -93.47 163.8 13.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.991 -1.068 . . . . 4.66 110.461 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.485 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 97.9 mt-10 -101.87 13.12 35.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.326 -0.859 . . . . 2.49 110.388 -175.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.406 ' HB3' ' HD3' ' A' ' 173' ' ' ARG . 1.3 tt0 -93.07 109.91 42.64 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.37 -0.831 . . . . 2.35 109.717 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 12.6 Cg_exo -71.88 -156.43 0.05 OUTLIER 'Trans proline' 0 C--N 1.301 -1.931 0 O-C-N 124.186 1.624 . . . . 1.92 110.638 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.438 ' HB2' HG23 ' A' ' 103' ' ' ILE . . . -80.46 52.96 1.72 Allowed 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 120.182 -0.607 . . . . 2.72 110.094 -178.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' SER . . . . . 0.467 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 13.5 t -80.69 128.03 33.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.325 -0.86 . . . . 4.22 109.971 177.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.468 ' O ' ' HG2' ' A' ' 179' ' ' GLU . 84.2 tt0 60.05 15.54 5.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.332 -0.855 . . . . 5.7 110.391 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 62.7 t -117.98 123.77 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.157 -0.964 . . . . 3.26 110.229 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.512 ' N ' ' CD2' ' A' ' 181' ' ' LEU . 0.1 OUTLIER -141.64 79.85 1.7 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.193 -0.942 . . . . 6.41 110.078 177.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -61.69 144.08 55.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.234 -0.916 . . . . 6.87 110.2 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -59.97 140.03 57.02 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.264 -0.897 . . . . 7.34 110.078 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 147.47 69.22 0.01 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.381 -1.487 . . . . 8.39 109.381 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 CA-C-O 117.984 -1.453 . . . . 10.46 109.494 -179.457 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.6 mtp . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.28 0.562 . . . . 10.42 110.172 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.431 ' HG2' ' HB2' ' A' ' 4' ' ' ASN . 85.8 tt0 -59.94 -40.07 87.71 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.307 -0.871 . . . . 6.2400000000000002 110.061 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.0 m 51.82 49.97 19.64 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.249 -0.907 . . . . 5.4299999999999997 110.322 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.431 ' HB2' ' HG2' ' A' ' 2' ' ' GLU . 11.4 t-20 -93.55 120.24 33.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.264 -0.898 . . . . 3.54 110.278 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -148.14 -170.76 3.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.293 -0.88 . . . . 2.6800000000000002 109.97 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.486 ' HA3' ' HG2' ' A' ' 88' ' ' ARG . . . -147.4 -159.72 8.5 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.523 -1.431 . . . . 0.75 109.523 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.899 HD13 HD21 ' A' ' 33' ' ' LEU . 43.6 pt -139.6 152.04 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.242 -1.152 . . . . 0.69999999999999996 110.007 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.7 mt -97.42 119.61 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.316 -0.865 . . . . 1.0600000000000001 109.81 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.761 HD11 ' HB ' ' A' ' 67' ' ' VAL . 2.2 pt? -135.87 -168.34 2.2 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.307 -0.871 . . . . 1.3400000000000001 110.255 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.559 ' CG ' ' HA2' ' A' ' 82' ' ' GLY . 26.5 ttm105 -106.0 130.69 53.88 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.302 -0.874 . . . . 3.2999999999999998 111.023 -174.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.856 HG11 ' O ' ' A' ' 80' ' ' SER . 14.4 p -61.66 139.02 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.473 -0.767 . . . . 0.78000000000000003 110.379 177.083 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.584 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -120.26 153.57 36.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.342 -0.849 . . . . 0.79000000000000004 110.481 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.595 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.5 tt0 -176.43 148.45 0.75 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.247 -0.908 . . . . 1.8400000000000001 110.297 175.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -130.39 159.97 35.42 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.314 -0.866 . . . . 2.27 110.358 -177.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -52.01 -27.04 12.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.331 -0.856 . . . . 5.3600000000000003 110.384 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.447 ' O ' ' OD1' ' A' ' 18' ' ' ASP . 60.1 p -59.94 159.86 8.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.13 -0.981 . . . . 5.9299999999999997 110.076 -177.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.469 ' O ' ' C ' ' A' ' 18' ' ' ASP . 81.9 p -60.0 -40.03 87.82 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.199 -0.938 . . . . 5.25 110.395 -176.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.553 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 4.7 p-10 36.43 59.97 3.35 Favored Pre-proline 0 N--CA 1.499 2.022 0 O-C-N 121.471 -0.768 . . . . 4.0899999999999999 110.573 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.553 ' HD3' ' N ' ' A' ' 18' ' ' ASP . 17.3 Cg_exo -62.0 167.37 10.69 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.919 1.484 . . . . 3.7200000000000002 110.526 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.71 83.35 1.67 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.779 -1.328 . . . . 1.97 109.779 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 23.7 ptm -89.81 -10.02 46.99 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.242 -1.152 . . . . 2.25 110.092 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 94.1 p -99.39 1.9 44.71 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.242 -0.911 . . . . 2.02 110.081 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.578 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 84.2 mtt85 -110.89 129.46 55.87 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.417 -0.802 . . . . 3.3799999999999999 109.906 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.914 HG13 HG23 ' A' ' 67' ' ' VAL . 77.9 t -109.95 115.4 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.012 -1.055 . . . . 0.64000000000000001 109.973 177.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.579 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.7 OUTLIER -88.09 117.43 26.96 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 118.81 -1.156 . . . . 2.5600000000000001 109.695 178.389 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.786 HD13 HG12 ' A' ' 24' ' ' VAL . 1.2 mp -129.12 172.61 11.24 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.757 -0.589 . . . . 2.4199999999999999 109.562 -177.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.538 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 7.0 p-10 -92.75 176.65 6.36 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.927 -1.108 . . . . 1.47 110.057 178.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.414 ' HG3' ' H ' ' A' ' 28' ' ' GLU . 40.4 mt-10 -59.99 -40.01 87.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.191 -0.943 . . . . 2.1099999999999999 109.482 -176.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.578 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 47.6 t -69.57 -44.91 69.88 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.434 -0.791 . . . . 1.51 110.564 -177.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.661 ' HA ' ' CD2' ' A' ' 33' ' ' LEU . 58.8 m -60.03 -39.98 87.75 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.091 -1.006 . . . . 1.4099999999999999 109.578 177.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.55 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 36.9 ttp180 -74.75 -43.39 55.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.765 -0.584 . . . . 2.6499999999999999 111.428 177.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.6 ttp180 -91.37 -11.55 37.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.836 -1.165 . . . . 3.3900000000000001 111.216 -169.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.089 HD12 ' N ' ' A' ' 34' ' ' LEU . 1.3 pp -58.68 -32.84 69.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.864 -1.147 . . . . 1.6200000000000001 109.594 -178.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.089 ' N ' HD12 ' A' ' 33' ' ' LEU . 13.0 mt -105.23 -74.05 0.66 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.192 -0.943 . . . . 2.0 110.309 175.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.559 ' O ' ' C ' ' A' ' 36' ' ' ALA . 45.6 t0 -170.17 -24.56 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.642 -0.661 . . . . 2.02 109.921 -179.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.691 ' HB1' HG21 ' A' ' 54' ' ' VAL . . . -24.57 119.19 0.05 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.58 0.705 . . . . 0.96999999999999997 111.383 -177.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.696 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.1 pt-20 -105.72 175.14 5.6 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.886 -0.783 . . . . 2.6400000000000001 108.886 175.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.42 HD11 ' NH1' ' A' ' 31' ' ' ARG . 26.1 mm -58.17 120.78 4.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 120.96 -1.087 . . . . 2.9100000000000001 109.835 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.576 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 74.66 33.85 54.88 Favored Glycine 0 N--CA 1.487 2.092 0 C-N-CA 119.961 -1.114 . . . . 0.98999999999999999 110.395 174.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.434 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 35.1 m-20 -89.15 177.11 6.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.742 -1.446 . . . . 1.3300000000000001 109.463 171.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.54 HG21 HG23 ' A' ' 92' ' ' THR . 70.4 t -99.04 121.6 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.985 -1.072 . . . . 0.5 110.241 -176.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.478 HG22 ' C ' ' A' ' 52' ' ' GLY . 1.5 m -116.8 139.43 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.34 -0.85 . . . . 0.41999999999999998 110.471 -176.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -106.83 141.31 38.26 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.397 -0.815 . . . . 1.4399999999999999 109.866 177.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.874 HD13 ' CE ' ' A' ' 73' ' ' MET . 2.1 mp -120.46 146.6 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 120.965 -1.084 . . . . 0.75 110.33 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 85.9 tt0 -150.9 97.12 2.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.251 -0.906 . . . . 1.3899999999999999 110.971 -178.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 1.021 ' CG ' HG12 ' A' ' 85' ' ' VAL . 1.7 tmtt? -98.39 -67.35 0.85 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.063 -1.023 . . . . 1.98 109.829 173.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.59 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -101.02 -35.42 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 121.775 0.797 . . . . 1.1699999999999999 109.158 174.299 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.523 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 72.0 mtt85 -135.46 -178.74 5.25 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.775 -0.578 . . . . 3.1099999999999999 109.592 178.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.578 ' C ' HD21 ' A' ' 130' ' ' LEU . 28.0 mttt -89.06 137.14 32.59 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.251 -0.906 . . . . 2.6000000000000001 110.62 -177.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.727 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 10.9 p -140.55 166.81 23.71 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.4 0.619 . . . . 1.1899999999999999 109.835 177.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.531 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.1 OUTLIER -123.01 166.18 18.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 121.466 -0.771 . . . . 0.56000000000000005 110.217 -179.715 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.478 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -178.97 -169.5 39.65 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 108.843 -1.703 . . . . 0.44 108.843 176.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -129.96 162.79 27.85 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.335 -1.097 . . . . 3.0600000000000001 110.169 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.696 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -89.01 138.83 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.193 -0.942 . . . . 0.70999999999999996 110.427 -173.843 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.578 ' CZ ' ' HD3' ' A' ' 23' ' ' ARG . 2.2 m-85 -134.74 166.32 23.22 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.528 -0.733 . . . . 1.29 110.251 177.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.514 ' HG3' ' O ' ' A' ' 56' ' ' ARG . 51.9 ptt85 -90.68 128.4 36.63 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.254 -0.904 . . . . 4.0300000000000002 110.213 178.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.573 ' HB1' ' OD1' ' A' ' 63' ' ' ASN . . . -65.93 140.01 58.3 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.277 -0.89 . . . . 1.3999999999999999 109.813 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.611 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -54.77 -49.54 90.98 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 120.914 -1.116 . . . . 4.0599999999999996 108.845 175.485 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.611 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 35.4 Cg_endo -92.73 98.83 0.17 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.87 1.458 . . . . 2.6600000000000001 108.877 178.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -73.53 34.38 0.08 Allowed 'General case' 0 C--N 1.29 -1.986 0 O-C-N 121.422 -0.799 . . . . 2.73 110.912 -174.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.401 ' H ' ' C ' ' A' ' 59' ' ' PRO . 54.6 t0 -146.25 -27.57 0.42 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.134 -0.979 . . . . 3.29 110.78 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -86.09 -28.18 24.21 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.122 -0.986 . . . . 3.6400000000000001 109.258 178.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.573 ' OD1' ' HB1' ' A' ' 57' ' ' ALA . 11.0 m120 -81.79 43.6 0.77 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.725 -0.61 . . . . 3.5499999999999998 110.301 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.433 ' HA ' ' CG ' ' A' ' 27' ' ' ASP . 30.3 pttt -97.43 8.95 43.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.302 -0.874 . . . . 4.3399999999999999 109.38 177.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.514 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -179.89 27.13 0.05 OUTLIER Glycine 0 N--CA 1.48 1.567 0 N-CA-C 109.383 -1.487 . . . . 0.94999999999999996 109.383 177.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.504 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 43.4 pt -140.28 142.9 30.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.364 -1.08 . . . . 1.04 109.376 175.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.914 HG23 HG13 ' A' ' 24' ' ' VAL . 3.1 p -119.99 121.1 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.032 -1.043 . . . . 0.62 110.082 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.584 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 97.3 mtt180 -89.82 116.05 27.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.077 -1.014 . . . . 3.7400000000000002 110.239 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.678 HD11 HG23 ' A' ' 11' ' ' VAL . 4.5 pt -126.76 171.7 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 CA-C-O 121.471 0.653 . . . . 0.93000000000000005 110.633 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -80.01 168.09 19.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.533 -0.729 . . . . 1.98 109.837 177.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 75.0 m -59.98 -40.0 87.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.233 -0.917 . . . . 1.8799999999999999 110.359 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.51 ' O ' ' ND2' ' A' ' 76' ' ' ASN . 54.5 t -62.83 -43.65 98.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.2 -0.937 . . . . 1.3999999999999999 110.203 -177.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.874 ' CE ' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -59.99 -46.51 89.24 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.179 -0.951 . . . . 1.1599999999999999 109.625 177.997 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.416 ' HD3' ' OE1' ' A' ' 13' ' ' GLU . 6.4 ttp-105 -60.17 -39.97 88.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.145 -0.972 . . . . 4.5300000000000002 109.579 174.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -69.97 -23.89 63.24 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.316 -0.865 . . . . 1.8300000000000001 110.478 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 72' ' ' VAL . 4.2 m120 -60.01 -39.12 84.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.124 -0.985 . . . . 1.6200000000000001 110.386 -177.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.534 ' C ' HG23 ' A' ' 47' ' ' VAL . 31.5 p -98.24 -35.05 10.48 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.035 -1.041 . . . . 1.98 110.545 -175.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.59 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 112.46 26.62 4.18 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.67 -1.372 . . . . 1.1200000000000001 109.67 176.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.731 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -103.46 169.99 8.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.219 -1.165 . . . . 1.02 110.303 -175.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.856 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -112.45 178.76 4.19 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.21 -0.931 . . . . 1.1799999999999999 109.368 178.267 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.595 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.1 OUTLIER -64.8 141.27 18.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 121.004 -1.06 . . . . 0.83999999999999997 110.342 177.492 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.803 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 78.65 -3.84 62.48 Favored Glycine 0 N--CA 1.48 1.603 0 N-CA-C 110.021 -1.231 . . . . 0.63 110.021 172.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.541 ' N ' HG12 ' A' ' 11' ' ' VAL . 1.2 m-20 -57.29 -167.57 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.174 0 O-C-N 120.911 -1.346 . . . . 1.5 110.062 175.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.566 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 50.8 pttt -127.03 114.68 18.1 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.139 -0.976 . . . . 1.73 109.736 178.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 1.021 HG12 ' CG ' ' A' ' 46' ' ' LYS . 1.1 m -119.36 155.58 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.169 -0.957 . . . . 0.52000000000000002 110.095 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 83.6 tttt -105.64 125.48 51.04 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.333 -0.854 . . . . 1.8600000000000001 110.036 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.668 HG23 HD21 ' A' ' 9' ' ' LEU . 74.6 t -106.82 121.35 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.248 -0.908 . . . . 0.45000000000000001 110.092 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.486 ' HG2' ' HA3' ' A' ' 6' ' ' GLY . 41.4 mtm180 -110.58 135.59 50.98 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.313 -0.867 . . . . 2.4700000000000002 109.568 178.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.483 ' HD2' ' N ' ' A' ' 36' ' ' ALA . 19.4 tttt -83.84 138.62 33.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.084 -1.01 . . . . 1.1899999999999999 110.3 -178.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.53 HG23 HG12 ' A' ' 41' ' ' VAL . 2.3 m -150.02 -168.69 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.472 -0.768 . . . . 0.53000000000000003 110.134 178.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -126.49 169.0 13.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.448 -0.783 . . . . 2.6899999999999999 109.927 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.54 HG23 HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -98.72 163.45 12.63 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.06 -1.025 . . . . 0.73999999999999999 111.026 -175.116 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.629 ' CG ' HG12 ' A' ' 162' ' ' VAL . 12.5 pt-20 -150.1 169.45 21.22 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.093 -0.706 . . . . 1.45 109.093 175.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.9 mm -89.61 100.43 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.608 -1.307 . . . . 0.93999999999999995 110.503 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.925 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -56.84 138.22 53.82 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.295 -0.878 . . . . 0.77000000000000002 110.261 177.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.546 ' CG ' ' HG ' ' A' ' 156' ' ' LEU . 16.9 ptpt -96.7 -29.36 13.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.21 -0.931 . . . . 2.4399999999999999 110.988 -179.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.576 ' HB3' HD23 ' A' ' 156' ' ' LEU . 16.1 tttp -150.68 124.65 9.27 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.744 -1.222 . . . . 2.0800000000000001 110.872 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 1.058 HG23 HG22 ' A' ' 155' ' ' THR . 5.4 p -134.35 142.03 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.13 -0.981 . . . . 0.39000000000000001 110.622 178.083 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.55 ' HB ' ' HB3' ' A' ' 154' ' ' LYS . 86.7 m -118.5 141.74 48.27 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.353 -0.842 . . . . 0.63 110.098 -178.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.535 ' N ' HD23 ' A' ' 100' ' ' LEU . 0.1 OUTLIER -139.26 169.78 17.14 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.248 -0.907 . . . . 1.3999999999999999 110.701 -178.11 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.717 ' HB2' ' HD2' ' A' ' 173' ' ' ARG . . . -141.16 99.69 6.51 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.367 -0.833 . . . . 0.83999999999999997 110.602 -176.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.735 ' HB3' HD11 ' A' ' 110' ' ' LEU . 22.5 Cg_exo -60.27 125.99 18.93 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.916 1.482 . . . . 1.04 110.221 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 1.011 HG23 ' HB2' ' A' ' 177' ' ' ALA . 83.4 mt -91.99 106.37 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.193 -0.942 . . . . 1.99 110.805 -177.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.763 HD12 ' HB2' ' A' ' 108' ' ' GLN . 1.9 pt -150.54 -173.91 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.224 -0.923 . . . . 1.3799999999999999 110.33 173.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.407 ' O ' ' HG2' ' A' ' 108' ' ' GLN . 82.4 mtp180 -140.62 -135.54 0.11 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.507 -0.745 . . . . 3.6600000000000001 109.869 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 16.9 mmtt -59.88 -13.48 11.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.925 -1.109 . . . . 2.7799999999999998 109.491 175.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.511 ' OD2' ' HB2' ' A' ' 145' ' ' GLN . 54.2 p-10 -99.88 28.73 4.58 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.299 0.571 . . . . 2.0899999999999999 109.819 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.763 ' HB2' HD12 ' A' ' 104' ' ' ILE . 12.8 pt20 -82.83 109.77 17.26 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.286 -0.883 . . . . 2.8900000000000001 109.988 -177.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 38.1 ttt85 -111.76 -13.42 13.72 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.641 -0.662 . . . . 4.3899999999999997 110.083 -178.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.735 HD11 ' HB3' ' A' ' 102' ' ' PRO . 0.8 OUTLIER -99.25 52.26 0.95 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.318 -0.863 . . . . 1.71 110.029 -178.53 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.428 ' O ' ' CD1' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -140.03 135.02 32.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.453 -0.779 . . . . 2.8700000000000001 109.865 176.75 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.508 ' HB2' HD13 ' A' ' 116' ' ' ILE . 10.0 m-85 -142.77 -40.06 0.33 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.184 -0.948 . . . . 2.7799999999999998 110.458 -177.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 114' ' ' GLU . . . 75.88 -176.24 51.29 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 108.978 -1.649 . . . . 1.71 108.978 -176.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.46 ' O ' ' O ' ' A' ' 113' ' ' GLY . 75.1 mm-40 41.48 94.45 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.186 -1.185 . . . . 2.4700000000000002 110.002 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.17 -7.42 75.47 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.594 -1.403 . . . . 1.1200000000000001 109.594 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.508 HD13 ' HB2' ' A' ' 112' ' ' PHE . 10.4 tp -60.02 -35.92 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.225 -1.162 . . . . 1.5 110.151 177.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.456 ' N ' HG23 ' A' ' 116' ' ' ILE . 43.5 mt-10 -59.97 -40.51 89.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.161 -0.962 . . . . 1.51 109.695 178.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -68.72 -38.94 80.61 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.174 -0.954 . . . . 2.1499999999999999 109.961 172.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.41 ' HD2' HD12 ' A' ' 116' ' ' ILE . 1.6 t80 -60.02 -40.05 87.95 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.269 -0.894 . . . . 1.49 109.359 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.955 HG21 HD11 ' A' ' 172' ' ' ILE . 55.1 t -66.99 -45.89 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.187 -0.945 . . . . 0.76000000000000001 109.931 174.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.565 ' O ' ' HB ' ' A' ' 125' ' ' ILE . 1.7 mt-30 -60.01 -44.41 94.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.423 -0.798 . . . . 1.8700000000000001 109.967 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 51.9 ttt180 -60.05 -48.63 80.91 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 121.456 0.646 . . . . 2.9700000000000002 110.126 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.569 ' C ' HD22 ' A' ' 124' ' ' LEU . . . -70.05 -40.09 75.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.433 -0.792 . . . . 0.93000000000000005 110.512 -178.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.669 HD22 ' N ' ' A' ' 124' ' ' LEU . 3.9 mm? -97.57 -0.04 46.55 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.253 -0.904 . . . . 1.9199999999999999 110.862 -175.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.649 ' HA ' HG22 ' A' ' 164' ' ' ILE . 2.5 tt -47.31 166.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 120.754 -1.216 . . . . 1.01 110.184 -175.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.528 ' N ' ' O ' ' A' ' 164' ' ' ILE . 34.1 ptt180 33.07 46.68 0.1 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.63 -0.669 . . . . 2.29 111.613 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 163' ' ' GLU . 7.6 mmt180 -129.82 150.39 75.71 Favored Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 120.687 -1.258 . . . . 2.6099999999999999 111.189 176.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.786 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 22.1 Cg_endo -67.21 130.78 23.41 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 124.179 1.621 . . . . 0.78000000000000003 109.871 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.544 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 87.7 mmm -127.17 137.63 52.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.553 -1.342 . . . . 1.8500000000000001 111.074 -177.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.633 HD23 ' HA ' ' A' ' 50' ' ' THR . 10.9 tp -140.23 113.64 8.55 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.668 -0.645 . . . . 1.29 109.517 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.559 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 1.0 OUTLIER -45.2 146.66 0.87 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.857 -1.152 . . . . 1.7 110.388 -176.924 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.559 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 73.84 -0.48 3.35 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.728 -0.607 . . . . 1.6599999999999999 110.603 179.576 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.565 ' OD2' HG21 ' A' ' 152' ' ' VAL . 3.2 p30 -69.97 -176.22 1.07 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.032 -1.043 . . . . 1.1399999999999999 110.008 174.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -145.93 150.03 35.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.297 -0.877 . . . . 1.1299999999999999 109.595 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.46 ' O ' ' HB2' ' A' ' 149' ' ' LEU . 0.2 OUTLIER -134.28 170.4 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.046 -1.034 . . . . 1.76 110.175 -179.575 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.6 t -136.51 165.8 25.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.4 -0.812 . . . . 2.8100000000000001 110.539 -176.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.582 ' CG1' ' HD2' ' A' ' 138' ' ' PRO . 2.7 t -112.06 147.82 37.74 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.392 -0.818 . . . . 2.8300000000000001 109.723 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.583 ' O ' HD12 ' A' ' 140' ' ' LEU . 1.4 Cg_endo -46.53 177.87 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.873 1.459 . . . . 3.8700000000000001 110.592 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.21 68.61 0.03 OUTLIER Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.983 -1.247 . . . . 4.3499999999999996 109.983 -176.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.919 ' C ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -130.0 154.81 47.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.207 -1.172 . . . . 5.9800000000000004 111.015 179.237 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.746 ' N ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER 176.97 -167.5 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.996 -1.065 . . . . 5.1600000000000001 110.263 -178.141 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.694 HD21 ' NE2' ' A' ' 145' ' ' GLN . 0.5 OUTLIER -146.06 -122.84 0.07 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.544 -0.723 . . . . 5.9000000000000004 109.853 178.151 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.523 ' H ' HD12 ' A' ' 142' ' ' LEU . . . -52.81 -161.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.141 -0.974 . . . . 6.9199999999999999 110.002 177.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -79.02 80.0 1.54 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.288 -1.525 . . . . 6.5199999999999996 109.288 173.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.694 ' NE2' HD21 ' A' ' 142' ' ' LEU . 1.9 pt20 -94.92 165.19 12.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.358 -1.084 . . . . 5.5599999999999996 110.07 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.8 t -140.04 153.72 46.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.208 -0.932 . . . . 5.7999999999999998 110.429 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.713 ' C ' HD23 ' A' ' 148' ' ' LEU . . . 80.21 -90.52 1.31 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.058 -1.617 . . . . 4.3399999999999999 109.058 -178.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.713 HD23 ' C ' ' A' ' 147' ' ' GLY . 0.4 OUTLIER 42.53 48.53 4.62 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.511 -0.994 . . . . 3.1800000000000002 110.802 176.502 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.709 HD11 HD12 ' A' ' 103' ' ' ILE . 2.6 pp -137.17 164.49 28.34 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.97 -1.081 . . . . 1.72 109.567 176.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -91.63 137.68 32.17 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.086 -1.009 . . . . 2.0099999999999998 110.234 -178.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.502 ' HB2' HD11 ' A' ' 103' ' ' ILE . 27.4 tptp -122.37 101.91 7.78 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.305 -0.872 . . . . 2.3799999999999999 109.577 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.565 HG21 ' OD2' ' A' ' 133' ' ' ASP . 2.3 t -77.47 138.83 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.222 -0.924 . . . . 0.66000000000000003 110.087 -177.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 4.2 t -129.71 -21.94 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.142 -0.974 . . . . 1.02 111.096 -177.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.55 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 10.5 tptm -139.91 129.84 24.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.69 -1.257 . . . . 2.8300000000000001 110.935 -179.011 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' THR . . . . . 1.058 HG22 HG23 ' A' ' 98' ' ' VAL . 67.2 p -130.49 164.58 24.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.465 -0.772 . . . . 0.69999999999999996 109.26 173.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.661 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -89.3 -36.67 0.42 Allowed Pre-proline 0 C--N 1.3 -1.576 0 O-C-N 121.159 -0.963 . . . . 1.6799999999999999 110.886 -176.568 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.988 ' CG ' HG11 ' A' ' 162' ' ' VAL . 31.4 Cg_exo -53.07 -174.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.419 0 O-C-N 123.407 1.214 . . . . 0.94999999999999996 110.397 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.471 ' O ' ' HB2' ' A' ' 159' ' ' LYS . 5.0 t -86.83 41.5 0.96 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.264 -0.897 . . . . 1.6100000000000001 110.239 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 158' ' ' SER . 40.7 mmtm 61.33 19.58 10.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.525 -0.734 . . . . 4.1900000000000004 109.878 -176.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.781 ' O ' HG13 ' A' ' 162' ' ' VAL . 23.3 m -102.25 159.91 27.94 Favored Pre-proline 0 C--N 1.304 -1.399 0 O-C-N 121.377 -0.827 . . . . 0.85999999999999999 109.779 175.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.531 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 5.4 Cg_endo -53.8 119.63 6.57 Favored 'Trans proline' 0 C--N 1.3 -2.024 0 O-C-N 124.078 1.567 . . . . 0.75 110.212 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.988 HG11 ' CG ' ' A' ' 157' ' ' PRO . 5.1 m -126.57 158.33 36.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.266 -0.896 . . . . 0.98999999999999999 109.874 176.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 127' ' ' ARG . 86.5 tt0 -104.58 128.7 52.65 Favored 'General case' 0 C--N 1.292 -1.901 0 O-C-N 121.188 -0.945 . . . . 1.75 110.063 177.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.841 ' CD1' HG21 ' A' ' 168' ' ' THR . 12.9 mm -71.05 152.69 8.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.678 -0.639 . . . . 0.78000000000000003 109.81 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -140.11 168.26 25.15 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.042 -1.623 . . . . 1.1599999999999999 109.042 175.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -56.3 -20.88 20.83 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.344 -1.092 . . . . 2.3700000000000001 110.015 -177.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -91.02 -18.52 24.48 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.329 -0.857 . . . . 2.1400000000000001 110.683 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.841 HG21 ' CD1' ' A' ' 164' ' ' ILE . 30.6 m -57.95 148.43 25.83 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.182 -0.949 . . . . 0.68000000000000005 110.486 -178.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.46 ' N ' ' O ' ' A' ' 96' ' ' LYS . 49.6 mttp -96.33 147.16 24.08 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.054 -1.029 . . . . 3.2400000000000002 109.733 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.741 HD13 ' CG1' ' A' ' 120' ' ' VAL . 1.8 mt -130.04 160.01 41.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.093 -1.004 . . . . 0.98999999999999999 110.984 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.472 ' HB3' HG23 ' A' ' 99' ' ' THR . 25.3 mt-10 -137.78 133.6 34.25 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.767 -0.583 . . . . 1.3700000000000001 110.215 176.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.955 HD11 HG21 ' A' ' 120' ' ' VAL . 39.4 mm -120.02 119.98 61.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.359 -0.838 . . . . 1.21 109.415 177.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.717 ' HD2' ' HB2' ' A' ' 101' ' ' ALA . 4.7 ptp85 -93.47 163.8 13.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.991 -1.068 . . . . 3.9399999999999999 110.461 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.478 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 97.9 mt-10 -101.87 13.12 35.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.326 -0.859 . . . . 2.4900000000000002 110.388 -175.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.43 ' HB3' ' HD3' ' A' ' 173' ' ' ARG . 1.3 tt0 -93.07 109.91 42.64 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.37 -0.831 . . . . 2.3500000000000001 109.717 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 12.6 Cg_exo -71.88 -156.43 0.05 OUTLIER 'Trans proline' 0 C--N 1.301 -1.931 0 O-C-N 124.186 1.624 . . . . 1.6299999999999999 110.638 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 1.011 ' HB2' HG23 ' A' ' 103' ' ' ILE . . . -80.46 52.96 1.72 Allowed 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 120.182 -0.607 . . . . 2.7200000000000002 110.094 -178.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' SER . . . . . 0.626 ' O ' HG23 ' A' ' 180' ' ' VAL . 13.5 t -80.69 128.03 33.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.325 -0.86 . . . . 3.8599999999999999 109.971 177.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.473 ' HB3' ' O ' ' A' ' 178' ' ' SER . 84.2 tt0 60.05 15.54 5.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.332 -0.855 . . . . 5.7000000000000002 110.391 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.768 ' C ' HD23 ' A' ' 181' ' ' LEU . 62.7 t -117.98 123.77 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.157 -0.964 . . . . 3.2200000000000002 110.229 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.768 HD23 ' C ' ' A' ' 180' ' ' VAL . 0.1 OUTLIER -141.64 79.85 1.7 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.193 -0.942 . . . . 6.0199999999999996 110.078 177.914 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -61.69 144.08 55.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.234 -0.916 . . . . 6.8700000000000001 110.2 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' GLU . . . . . 0.422 ' HG3' ' H ' ' A' ' 183' ' ' GLU . 12.1 mt-10 -59.97 140.03 57.02 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.264 -0.897 . . . . 6.8899999999999997 110.078 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 147.47 69.22 0.01 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.381 -1.487 . . . . 8.3900000000000006 109.381 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 CA-C-O 117.984 -1.453 . . . . 10.460000000000001 109.494 -179.457 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.6 mtp . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.28 0.562 . . . . 10.42 110.172 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.431 ' HG2' ' HB2' ' A' ' 4' ' ' ASN . 85.8 tt0 -59.94 -40.07 87.71 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.307 -0.871 . . . . 6.24 110.061 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.0 m 51.82 49.97 19.64 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.249 -0.907 . . . . 5.43 110.322 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.431 ' HB2' ' HG2' ' A' ' 2' ' ' GLU . 11.4 t-20 -93.55 120.24 33.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.264 -0.898 . . . . 3.54 110.278 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -148.14 -170.76 3.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.293 -0.88 . . . . 2.68 109.97 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.486 ' HA3' ' HG2' ' A' ' 88' ' ' ARG . . . -147.4 -159.72 8.5 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.523 -1.431 . . . . 0.75 109.523 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.899 HD13 HD21 ' A' ' 33' ' ' LEU . 43.6 pt -139.6 152.04 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.242 -1.152 . . . . 0.7 110.007 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.7 mt -97.42 119.61 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.316 -0.865 . . . . 1.06 109.81 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.761 HD11 ' HB ' ' A' ' 67' ' ' VAL . 2.2 pt? -135.87 -168.34 2.2 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.307 -0.871 . . . . 1.34 110.255 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.559 ' CG ' ' HA2' ' A' ' 82' ' ' GLY . 26.5 ttm105 -106.0 130.69 53.88 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.302 -0.874 . . . . 3.3 111.023 -174.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.856 HG11 ' O ' ' A' ' 80' ' ' SER . 14.4 p -61.66 139.02 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.473 -0.767 . . . . 0.78 110.379 177.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.584 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -120.26 153.57 36.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.342 -0.849 . . . . 0.79 110.481 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.595 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.5 tt0 -176.43 148.45 0.75 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.247 -0.908 . . . . 1.84 110.297 175.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -130.39 159.97 35.42 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.314 -0.866 . . . . 2.27 110.358 -177.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -52.01 -27.04 12.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.331 -0.856 . . . . 5.36 110.384 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.447 ' O ' ' OD1' ' A' ' 18' ' ' ASP . 60.1 p -59.94 159.86 8.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.13 -0.981 . . . . 5.93 110.076 -177.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.469 ' O ' ' C ' ' A' ' 18' ' ' ASP . 81.9 p -60.0 -40.03 87.82 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.199 -0.938 . . . . 5.25 110.395 -176.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.553 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 4.7 p-10 36.43 59.97 3.35 Favored Pre-proline 0 N--CA 1.499 2.022 0 O-C-N 121.471 -0.768 . . . . 4.09 110.573 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.553 ' HD3' ' N ' ' A' ' 18' ' ' ASP . 17.3 Cg_exo -62.0 167.37 10.69 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.919 1.484 . . . . 3.72 110.526 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.71 83.35 1.67 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.779 -1.328 . . . . 1.97 109.779 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 23.7 ptm -89.81 -10.02 46.99 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.242 -1.152 . . . . 2.25 110.092 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 94.1 p -99.39 1.9 44.71 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.242 -0.911 . . . . 2.02 110.081 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.578 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 84.2 mtt85 -110.89 129.46 55.87 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.417 -0.802 . . . . 3.38 109.906 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.914 HG13 HG23 ' A' ' 67' ' ' VAL . 77.9 t -109.95 115.4 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.012 -1.055 . . . . 0.64 109.973 177.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.579 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.7 OUTLIER -88.09 117.43 26.96 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 118.81 -1.156 . . . . 2.56 109.695 178.389 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.786 HD13 HG12 ' A' ' 24' ' ' VAL . 1.2 mp -129.12 172.61 11.24 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.757 -0.589 . . . . 2.42 109.562 -177.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.538 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 7.0 p-10 -92.75 176.65 6.36 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.927 -1.108 . . . . 1.47 110.057 178.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.414 ' HG3' ' H ' ' A' ' 28' ' ' GLU . 40.4 mt-10 -59.99 -40.01 87.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.191 -0.943 . . . . 2.11 109.482 -176.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.578 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 47.6 t -69.57 -44.91 69.88 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.434 -0.791 . . . . 1.51 110.564 -177.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.661 ' HA ' ' CD2' ' A' ' 33' ' ' LEU . 58.8 m -60.03 -39.98 87.75 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.091 -1.006 . . . . 1.41 109.578 177.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.55 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 36.9 ttp180 -74.75 -43.39 55.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.765 -0.584 . . . . 2.65 111.428 177.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.6 ttp180 -91.37 -11.55 37.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.836 -1.165 . . . . 3.39 111.216 -169.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.089 HD12 ' N ' ' A' ' 34' ' ' LEU . 1.3 pp -58.68 -32.84 69.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.864 -1.147 . . . . 1.62 109.594 -178.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.089 ' N ' HD12 ' A' ' 33' ' ' LEU . 13.0 mt -105.23 -74.05 0.66 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.192 -0.943 . . . . 2.0 110.309 175.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.559 ' O ' ' C ' ' A' ' 36' ' ' ALA . 45.6 t0 -170.17 -24.56 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.642 -0.661 . . . . 2.02 109.921 -179.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.691 ' HB1' HG21 ' A' ' 54' ' ' VAL . . . -24.57 119.19 0.05 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.58 0.705 . . . . 0.97 111.383 -177.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.696 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.1 pt-20 -105.72 175.14 5.6 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.886 -0.783 . . . . 2.64 108.886 175.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.42 HD11 ' NH1' ' A' ' 31' ' ' ARG . 26.1 mm -58.17 120.78 4.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 120.96 -1.087 . . . . 2.91 109.835 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.576 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 74.66 33.85 54.88 Favored Glycine 0 N--CA 1.487 2.092 0 C-N-CA 119.961 -1.114 . . . . 0.99 110.395 174.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.434 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 35.1 m-20 -89.15 177.11 6.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.742 -1.446 . . . . 1.33 109.463 171.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.54 HG21 HG23 ' A' ' 92' ' ' THR . 70.4 t -99.04 121.6 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.985 -1.072 . . . . 0.5 110.241 -176.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.478 HG22 ' C ' ' A' ' 52' ' ' GLY . 1.5 m -116.8 139.43 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.34 -0.85 . . . . 0.42 110.471 -176.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -106.83 141.31 38.26 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.397 -0.815 . . . . 1.44 109.866 177.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.874 HD13 ' CE ' ' A' ' 73' ' ' MET . 2.1 mp -120.46 146.6 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 120.965 -1.084 . . . . 0.75 110.33 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 85.9 tt0 -150.9 97.12 2.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.251 -0.906 . . . . 1.39 110.971 -178.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 1.021 ' CG ' HG12 ' A' ' 85' ' ' VAL . 1.7 tmtt? -98.39 -67.35 0.85 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.063 -1.023 . . . . 1.98 109.829 173.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.59 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -101.02 -35.42 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 121.775 0.797 . . . . 1.17 109.158 174.299 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.523 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 72.0 mtt85 -135.46 -178.74 5.25 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.775 -0.578 . . . . 3.11 109.592 178.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.578 ' C ' HD21 ' A' ' 130' ' ' LEU . 28.0 mttt -89.06 137.14 32.59 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.251 -0.906 . . . . 2.6 110.62 -177.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.727 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 10.9 p -140.55 166.81 23.71 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.4 0.619 . . . . 1.19 109.835 177.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.531 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.1 OUTLIER -123.01 166.18 18.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 121.466 -0.771 . . . . 0.56 110.217 -179.715 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.478 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -178.97 -169.5 39.65 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 108.843 -1.703 . . . . 0.44 108.843 176.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -129.96 162.79 27.85 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.335 -1.097 . . . . 3.06 110.169 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.696 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -89.01 138.83 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.193 -0.942 . . . . 0.71 110.427 -173.843 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.578 ' CZ ' ' HD3' ' A' ' 23' ' ' ARG . 2.2 m-85 -134.74 166.32 23.22 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.528 -0.733 . . . . 1.29 110.251 177.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.514 ' HG3' ' O ' ' A' ' 56' ' ' ARG . 51.9 ptt85 -90.68 128.4 36.63 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.254 -0.904 . . . . 4.03 110.213 178.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.717 ' HB1' ' ND2' ' A' ' 63' ' ' ASN . . . -65.93 140.01 58.3 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.277 -0.89 . . . . 1.4 109.813 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.611 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -54.77 -49.54 90.98 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 120.914 -1.116 . . . . 4.06 108.845 175.485 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.611 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 35.4 Cg_endo -92.73 98.83 0.17 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.87 1.458 . . . . 2.66 108.877 178.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -73.53 34.38 0.08 Allowed 'General case' 0 C--N 1.29 -1.986 0 O-C-N 121.422 -0.799 . . . . 2.73 110.912 -174.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.401 ' H ' ' C ' ' A' ' 59' ' ' PRO . 54.6 t0 -146.25 -27.57 0.42 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.134 -0.979 . . . . 3.29 110.78 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -86.09 -28.18 24.21 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.122 -0.986 . . . . 3.64 109.258 178.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.717 ' ND2' ' HB1' ' A' ' 57' ' ' ALA . 33.4 m-80 -81.79 43.6 0.77 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.725 -0.61 . . . . 3.55 110.301 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.433 ' HA ' ' CG ' ' A' ' 27' ' ' ASP . 30.3 pttt -97.43 8.95 43.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.302 -0.874 . . . . 4.34 109.38 177.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.514 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -179.89 27.13 0.05 OUTLIER Glycine 0 N--CA 1.48 1.567 0 N-CA-C 109.383 -1.487 . . . . 0.95 109.383 177.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.504 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 43.4 pt -140.28 142.9 30.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.364 -1.08 . . . . 1.04 109.376 175.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.914 HG23 HG13 ' A' ' 24' ' ' VAL . 3.1 p -119.99 121.1 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.032 -1.043 . . . . 0.62 110.082 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.584 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 97.3 mtt180 -89.82 116.05 27.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.077 -1.014 . . . . 3.74 110.239 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.678 HD11 HG23 ' A' ' 11' ' ' VAL . 4.5 pt -126.76 171.7 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 CA-C-O 121.471 0.653 . . . . 0.93 110.633 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -80.01 168.09 19.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.533 -0.729 . . . . 1.98 109.837 177.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 75.0 m -59.98 -40.0 87.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.233 -0.917 . . . . 1.88 110.359 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.51 ' O ' ' ND2' ' A' ' 76' ' ' ASN . 54.5 t -62.83 -43.65 98.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.2 -0.937 . . . . 1.4 110.203 -177.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.874 ' CE ' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -59.99 -46.51 89.24 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.179 -0.951 . . . . 1.16 109.625 177.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.416 ' HD3' ' OE1' ' A' ' 13' ' ' GLU . 6.4 ttp-105 -60.17 -39.97 88.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.145 -0.972 . . . . 4.53 109.579 174.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -69.97 -23.89 63.24 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.316 -0.865 . . . . 1.83 110.478 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 72' ' ' VAL . 4.2 m120 -60.01 -39.12 84.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.124 -0.985 . . . . 1.62 110.386 -177.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.534 ' C ' HG23 ' A' ' 47' ' ' VAL . 31.5 p -98.24 -35.05 10.48 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.035 -1.041 . . . . 1.98 110.545 -175.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.59 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 112.46 26.62 4.18 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.67 -1.372 . . . . 1.12 109.67 176.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.731 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -103.46 169.99 8.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.219 -1.165 . . . . 1.02 110.303 -175.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.856 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -112.45 178.76 4.19 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.21 -0.931 . . . . 1.18 109.368 178.267 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.595 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.1 OUTLIER -64.8 141.27 18.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 121.004 -1.06 . . . . 0.84 110.342 177.492 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.803 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 78.65 -3.84 62.48 Favored Glycine 0 N--CA 1.48 1.603 0 N-CA-C 110.021 -1.231 . . . . 0.63 110.021 172.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.541 ' N ' HG12 ' A' ' 11' ' ' VAL . 1.2 m-20 -57.29 -167.57 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.174 0 O-C-N 120.911 -1.346 . . . . 1.5 110.062 175.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.566 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 50.8 pttt -127.03 114.68 18.1 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.139 -0.976 . . . . 1.73 109.736 178.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 1.021 HG12 ' CG ' ' A' ' 46' ' ' LYS . 1.1 m -119.36 155.58 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.169 -0.957 . . . . 0.52 110.095 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 83.6 tttt -105.64 125.48 51.04 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.333 -0.854 . . . . 1.86 110.036 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.668 HG23 HD21 ' A' ' 9' ' ' LEU . 74.6 t -106.82 121.35 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.248 -0.908 . . . . 0.45 110.092 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.486 ' HG2' ' HA3' ' A' ' 6' ' ' GLY . 41.4 mtm180 -110.58 135.59 50.98 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.313 -0.867 . . . . 2.47 109.568 178.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.483 ' HD2' ' N ' ' A' ' 36' ' ' ALA . 19.4 tttt -83.84 138.62 33.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.084 -1.01 . . . . 1.19 110.3 -178.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.53 HG23 HG12 ' A' ' 41' ' ' VAL . 2.3 m -150.02 -168.69 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.472 -0.768 . . . . 0.53 110.134 178.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -126.49 169.0 13.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.448 -0.783 . . . . 2.69 109.927 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.54 HG23 HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -98.72 163.45 12.63 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.06 -1.025 . . . . 0.74 111.026 -175.116 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.629 ' CG ' HG12 ' A' ' 162' ' ' VAL . 12.5 pt-20 -150.1 169.45 21.22 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.093 -0.706 . . . . 1.45 109.093 175.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.9 mm -89.61 100.43 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.608 -1.307 . . . . 0.94 110.503 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.925 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -56.84 138.22 53.82 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.295 -0.878 . . . . 0.77 110.261 177.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.546 ' CG ' ' HG ' ' A' ' 156' ' ' LEU . 16.9 ptpt -96.7 -29.36 13.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.21 -0.931 . . . . 2.44 110.988 -179.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.576 ' HB3' HD23 ' A' ' 156' ' ' LEU . 16.1 tttp -150.68 124.65 9.27 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.744 -1.222 . . . . 2.08 110.872 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 1.058 HG23 HG22 ' A' ' 155' ' ' THR . 5.4 p -134.35 142.03 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.13 -0.981 . . . . 0.39 110.622 178.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.55 ' HB ' ' HB3' ' A' ' 154' ' ' LYS . 86.7 m -118.5 141.74 48.27 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.353 -0.842 . . . . 0.63 110.098 -178.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.535 HD23 ' N ' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -139.26 169.78 17.14 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.248 -0.907 . . . . 1.4 110.701 -178.11 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.717 ' HB2' ' HD2' ' A' ' 173' ' ' ARG . . . -141.16 99.69 6.51 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.367 -0.833 . . . . 0.84 110.602 -176.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.735 ' HB3' HD11 ' A' ' 110' ' ' LEU . 22.5 Cg_exo -60.27 125.99 18.93 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.916 1.482 . . . . 1.04 110.221 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 1.011 HG23 ' HB2' ' A' ' 177' ' ' ALA . 83.4 mt -91.99 106.37 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.193 -0.942 . . . . 1.99 110.805 -177.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.763 HD12 ' HB2' ' A' ' 108' ' ' GLN . 1.9 pt -150.54 -173.91 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.224 -0.923 . . . . 1.38 110.33 173.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.407 ' O ' ' HG2' ' A' ' 108' ' ' GLN . 82.4 mtp180 -140.62 -135.54 0.11 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.507 -0.745 . . . . 3.66 109.869 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 16.9 mmtt -59.88 -13.48 11.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.925 -1.109 . . . . 2.78 109.491 175.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.511 ' OD2' ' HB2' ' A' ' 145' ' ' GLN . 54.2 p-10 -99.88 28.73 4.58 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.299 0.571 . . . . 2.09 109.819 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.763 ' HB2' HD12 ' A' ' 104' ' ' ILE . 12.8 pt20 -82.83 109.77 17.26 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.286 -0.883 . . . . 2.89 109.988 -177.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 38.1 ttt85 -111.76 -13.42 13.72 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.641 -0.662 . . . . 4.39 110.083 -178.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.735 HD11 ' HB3' ' A' ' 102' ' ' PRO . 0.8 OUTLIER -99.25 52.26 0.95 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.318 -0.863 . . . . 1.71 110.029 -178.53 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.428 ' O ' ' CD1' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -140.03 135.02 32.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.453 -0.779 . . . . 2.87 109.865 176.75 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.508 ' HB2' HD13 ' A' ' 116' ' ' ILE . 10.0 m-85 -142.77 -40.06 0.33 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.184 -0.948 . . . . 2.78 110.458 -177.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 114' ' ' GLU . . . 75.88 -176.24 51.29 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 108.978 -1.649 . . . . 1.71 108.978 -176.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.46 ' O ' ' O ' ' A' ' 113' ' ' GLY . 75.1 mm-40 41.48 94.45 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.186 -1.185 . . . . 2.47 110.002 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.17 -7.42 75.47 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.594 -1.403 . . . . 1.12 109.594 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.508 HD13 ' HB2' ' A' ' 112' ' ' PHE . 10.4 tp -60.02 -35.92 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.225 -1.162 . . . . 1.5 110.151 177.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.456 ' N ' HG23 ' A' ' 116' ' ' ILE . 43.5 mt-10 -59.97 -40.51 89.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.161 -0.962 . . . . 1.51 109.695 178.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -68.72 -38.94 80.61 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.174 -0.954 . . . . 2.15 109.961 172.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.41 ' HD2' HD12 ' A' ' 116' ' ' ILE . 1.6 t80 -60.02 -40.05 87.95 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.269 -0.894 . . . . 1.49 109.359 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.955 HG21 HD11 ' A' ' 172' ' ' ILE . 55.1 t -66.99 -45.89 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.187 -0.945 . . . . 0.76 109.931 174.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.565 ' O ' ' HB ' ' A' ' 125' ' ' ILE . 4.2 mt-30 -60.01 -44.41 94.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.423 -0.798 . . . . 1.87 109.967 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 51.9 ttt180 -60.05 -48.63 80.91 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 121.456 0.646 . . . . 2.97 110.126 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.569 ' C ' HD22 ' A' ' 124' ' ' LEU . . . -70.05 -40.09 75.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.433 -0.792 . . . . 0.93 110.512 -178.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.669 ' N ' HD22 ' A' ' 124' ' ' LEU . 3.9 mm? -97.57 -0.04 46.55 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.253 -0.904 . . . . 1.92 110.862 -175.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.649 ' HA ' HG22 ' A' ' 164' ' ' ILE . 2.5 tt -47.31 166.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 120.754 -1.216 . . . . 1.01 110.184 -175.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.528 ' N ' ' O ' ' A' ' 164' ' ' ILE . 34.1 ptt180 33.07 46.68 0.1 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.63 -0.669 . . . . 2.29 111.613 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 163' ' ' GLU . 7.6 mmt180 -129.82 150.39 75.71 Favored Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 120.687 -1.258 . . . . 2.61 111.189 176.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.786 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 22.1 Cg_endo -67.21 130.78 23.41 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 124.179 1.621 . . . . 0.78 109.871 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.544 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 87.7 mmm -127.17 137.63 52.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.553 -1.342 . . . . 1.85 111.074 -177.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.633 HD23 ' HA ' ' A' ' 50' ' ' THR . 10.9 tp -140.23 113.64 8.55 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.668 -0.645 . . . . 1.29 109.517 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.559 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 1.0 OUTLIER -45.2 146.66 0.87 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.857 -1.152 . . . . 1.7 110.388 -176.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.559 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 73.84 -0.48 3.35 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.728 -0.607 . . . . 1.66 110.603 179.576 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.565 ' OD2' HG21 ' A' ' 152' ' ' VAL . 3.2 p30 -69.97 -176.22 1.07 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.032 -1.043 . . . . 1.14 110.008 174.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -145.93 150.03 35.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.297 -0.877 . . . . 1.13 109.595 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.46 ' O ' ' HB2' ' A' ' 149' ' ' LEU . 0.2 OUTLIER -134.28 170.4 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.046 -1.034 . . . . 1.76 110.175 -179.575 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.6 t -136.51 165.8 25.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.4 -0.812 . . . . 2.81 110.539 -176.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.582 ' CG1' ' HD2' ' A' ' 138' ' ' PRO . 2.7 t -112.06 147.82 37.74 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.392 -0.818 . . . . 2.83 109.723 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.583 ' O ' HD12 ' A' ' 140' ' ' LEU . 1.4 Cg_endo -46.53 177.87 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.873 1.459 . . . . 3.87 110.592 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.21 68.61 0.03 OUTLIER Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.983 -1.247 . . . . 4.35 109.983 -176.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.919 ' C ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -130.0 154.81 47.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.207 -1.172 . . . . 5.98 111.015 179.237 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.746 ' N ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER 176.97 -167.5 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.996 -1.065 . . . . 5.16 110.263 -178.141 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.694 HD21 ' NE2' ' A' ' 145' ' ' GLN . 0.5 OUTLIER -146.06 -122.84 0.07 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.544 -0.723 . . . . 5.9 109.853 178.151 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.523 ' H ' HD12 ' A' ' 142' ' ' LEU . . . -52.81 -161.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.141 -0.974 . . . . 6.92 110.002 177.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -79.02 80.0 1.54 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.288 -1.525 . . . . 6.52 109.288 173.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.694 ' NE2' HD21 ' A' ' 142' ' ' LEU . 1.9 pt20 -94.92 165.19 12.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.358 -1.084 . . . . 5.56 110.07 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.8 t -140.04 153.72 46.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.208 -0.932 . . . . 5.8 110.429 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.713 ' C ' HD23 ' A' ' 148' ' ' LEU . . . 80.21 -90.52 1.31 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.058 -1.617 . . . . 4.34 109.058 -178.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.713 HD23 ' C ' ' A' ' 147' ' ' GLY . 0.4 OUTLIER 42.53 48.53 4.62 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.511 -0.994 . . . . 3.18 110.802 176.502 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.709 HD11 HD12 ' A' ' 103' ' ' ILE . 2.6 pp -137.17 164.49 28.34 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.97 -1.081 . . . . 1.72 109.567 176.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -91.63 137.68 32.17 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.086 -1.009 . . . . 2.01 110.234 -178.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.502 ' HB2' HD11 ' A' ' 103' ' ' ILE . 27.4 tptp -122.37 101.91 7.78 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.305 -0.872 . . . . 2.38 109.577 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.565 HG21 ' OD2' ' A' ' 133' ' ' ASP . 2.3 t -77.47 138.83 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.222 -0.924 . . . . 0.66 110.087 -177.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 4.2 t -129.71 -21.94 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.142 -0.974 . . . . 1.02 111.096 -177.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.55 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 10.5 tptm -139.91 129.84 24.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.69 -1.257 . . . . 2.83 110.935 -179.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 1.058 HG22 HG23 ' A' ' 98' ' ' VAL . 67.2 p -130.49 164.58 24.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.465 -0.772 . . . . 0.7 109.26 173.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.661 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -89.3 -36.67 0.42 Allowed Pre-proline 0 C--N 1.3 -1.576 0 O-C-N 121.159 -0.963 . . . . 1.68 110.886 -176.568 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.988 ' CG ' HG11 ' A' ' 162' ' ' VAL . 31.4 Cg_exo -53.07 -174.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.419 0 O-C-N 123.407 1.214 . . . . 0.95 110.397 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.471 ' O ' ' HB2' ' A' ' 159' ' ' LYS . 5.0 t -86.83 41.5 0.96 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.264 -0.897 . . . . 1.61 110.239 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 158' ' ' SER . 40.7 mmtm 61.33 19.58 10.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.525 -0.734 . . . . 4.19 109.878 -176.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.781 ' O ' HG13 ' A' ' 162' ' ' VAL . 23.3 m -102.25 159.91 27.94 Favored Pre-proline 0 C--N 1.304 -1.399 0 O-C-N 121.377 -0.827 . . . . 0.86 109.779 175.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.531 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 5.4 Cg_endo -53.8 119.63 6.57 Favored 'Trans proline' 0 C--N 1.3 -2.024 0 O-C-N 124.078 1.567 . . . . 0.75 110.212 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.988 HG11 ' CG ' ' A' ' 157' ' ' PRO . 5.1 m -126.57 158.33 36.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.266 -0.896 . . . . 0.99 109.874 176.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 127' ' ' ARG . 86.5 tt0 -104.58 128.7 52.65 Favored 'General case' 0 C--N 1.292 -1.901 0 O-C-N 121.188 -0.945 . . . . 1.75 110.063 177.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.841 ' CD1' HG21 ' A' ' 168' ' ' THR . 12.9 mm -71.05 152.69 8.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.678 -0.639 . . . . 0.78 109.81 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -140.11 168.26 25.15 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.042 -1.623 . . . . 1.16 109.042 175.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -56.3 -20.88 20.83 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.344 -1.092 . . . . 2.37 110.015 -177.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -91.02 -18.52 24.48 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.329 -0.857 . . . . 2.14 110.683 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.841 HG21 ' CD1' ' A' ' 164' ' ' ILE . 30.6 m -57.95 148.43 25.83 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.182 -0.949 . . . . 0.68 110.486 -178.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.46 ' N ' ' O ' ' A' ' 96' ' ' LYS . 49.6 mttp -96.33 147.16 24.08 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.054 -1.029 . . . . 3.24 109.733 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.741 HD13 ' CG1' ' A' ' 120' ' ' VAL . 1.8 mt -130.04 160.01 41.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.093 -1.004 . . . . 0.99 110.984 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.472 ' HB3' HG23 ' A' ' 99' ' ' THR . 25.3 mt-10 -137.78 133.6 34.25 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.767 -0.583 . . . . 1.37 110.215 176.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.955 HD11 HG21 ' A' ' 120' ' ' VAL . 39.4 mm -120.02 119.98 61.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.359 -0.838 . . . . 1.21 109.415 177.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.717 ' HD2' ' HB2' ' A' ' 101' ' ' ALA . 4.7 ptp85 -93.47 163.8 13.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.991 -1.068 . . . . 3.94 110.461 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.478 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 97.9 mt-10 -101.87 13.12 35.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.326 -0.859 . . . . 2.49 110.388 -175.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.43 ' HB3' ' HD3' ' A' ' 173' ' ' ARG . 1.3 tt0 -93.07 109.91 42.64 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.37 -0.831 . . . . 2.35 109.717 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 12.6 Cg_exo -71.88 -156.43 0.05 OUTLIER 'Trans proline' 0 C--N 1.301 -1.931 0 O-C-N 124.186 1.624 . . . . 1.63 110.638 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 1.011 ' HB2' HG23 ' A' ' 103' ' ' ILE . . . -80.46 52.96 1.72 Allowed 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 120.182 -0.607 . . . . 2.72 110.094 -178.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . 0.626 ' O ' HG23 ' A' ' 180' ' ' VAL . 13.5 t -80.69 128.03 33.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.325 -0.86 . . . . 3.86 109.971 177.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.473 ' HB3' ' O ' ' A' ' 178' ' ' SER . 84.2 tt0 60.05 15.54 5.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.332 -0.855 . . . . 5.7 110.391 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.768 ' C ' HD23 ' A' ' 181' ' ' LEU . 62.7 t -117.98 123.77 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.157 -0.964 . . . . 3.22 110.229 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.768 HD23 ' C ' ' A' ' 180' ' ' VAL . 0.1 OUTLIER -141.64 79.85 1.7 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.193 -0.942 . . . . 6.02 110.078 177.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -61.69 144.08 55.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.234 -0.916 . . . . 6.87 110.2 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . 0.422 ' HG3' ' H ' ' A' ' 183' ' ' GLU . 12.1 mt-10 -59.97 140.03 57.02 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.264 -0.897 . . . . 6.89 110.078 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 147.47 69.22 0.01 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.381 -1.487 . . . . 8.39 109.381 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 CA-C-O 117.984 -1.453 . . . . 10.46 109.494 -179.457 . . . . . . . . 0 0 . 1 stop_ save_